Authors

  • Teshayeva Nozigul Ҳамидулло қизи

Author Biography

  • Teshayeva Nozigul Ҳамидулло қизи

    Bukhara State Medical Institute named after Abu Ali Ibn Sino

    Tel : +998911329697

    Nozigulteshayeva@gmail.com

DOI:

https://doi.org/10.71337/inlibrary.uz.mead.118269

Abstract

Recurrent aphthous stomatitis (RAS) is one of the most common oral mucosal diseases characterized by recurrent and painful ulcerations on the movable or nonkeratinized oral mucosae. Clinically, three types of RAS, namely minor, major, and herpetiform types, can be identified. RAS more commonly affects labial mucosabuccal mucosa, and tongue. Previous studies indicate that RAS is a multifactorial T cell-mediated immune-dysregulated disease. Factors that modify the immunologic responses in RAS include genetic predisposition, viral and bacterial infections, food allergies, vitamin and microelement deficiencies, systemic diseases, hormonal imbalance, mechanical injuries, and stress. Our previous study found the presence of serum gastric parietal cell antibodythyroglobulin antibody, and thyroid microsomal antibody in 13.0%, 19.4%, and 19.7% of 355 RAS patients, respectively. We also found anemiaserum ironvitamin B12, and folic acid deficiencies, and hyperhomocysteinemia in 20.9%, 20.1%, 4.8%, 2.6%, and 7.7% of 273 RAS patients, respectively. Therefore, it is very important to examine the complete blood count, serum autoantibody, hematinic, and homocysteine levels in RAS patients before we start to offer treatments for RAS. Because RAS is an immunologically-mediated disease, topical and systemic corticosteroid therapies are the main treatments of choice for RAS.


background image

MODERN EDUCATION AND DEVELOPMENT

Выпуск журнала №-24

Часть–1_Апрел –2025

270

RECURRENT APHTHOUS STOMATITIS – ETIOLOGY, SERUM

AUTOANTIBODIES, ANEMIA, HEMATINIC DEFICIENCIES, AND

MANAGEMENT

Teshayeva Nozigul Ҳамидулло қизи

Bukhara State Medical Institute named after Abu Ali Ibn Sino

Tel : +998911329697

Nozigulteshayeva@gmail.com

ABSTRACT

.

Recurrent aphthous stomatitis (RAS) is one of the most

common oral mucosal diseases characterized by recurrent and painful ulcerations on

the movable or nonkeratinized oral mucosae. Clinically, three types of RAS, namely

minor, major, and herpetiform types, can be identified. RAS more commonly affects

labial mucosa, buccal mucosa, and tongue. Previous studies indicate that RAS is a

multifactorial T cell-mediated immune-dysregulated disease. Factors that modify the

immunologic responses in RAS include genetic predisposition, viral and bacterial

infections, food allergies, vitamin and microelement deficiencies, systemic diseases,

hormonal imbalance, mechanical injuries, and stress. Our previous study found the

presence of serum gastric parietal cell antidiv, thyroglobulin antidiv,

and thyroid microsomal antidiv in 13.0%, 19.4%, and 19.7% of 355 RAS patients,

respectively. We also found anemia, serum iron, vitamin B12, and folic acid

deficiencies, and hyperhomocysteinemia in 20.9%, 20.1%, 4.8%, 2.6%, and 7.7% of

273 RAS patients, respectively. Therefore, it is very important to examine the

complete blood count, serum autoantidiv, hematinic, and homocysteine levels in

RAS patients before we start to offer treatments for RAS. Because RAS is an

immunologically-mediated disease, topical and systemic corticosteroid therapies are

the main treatments of choice for RAS.

Introduction

Recurrent aphthous stomatitis (RAS) is one of the most common oral mucosal

diseases characterized by recurrent and painful ulcerations on the movable or


background image

MODERN EDUCATION AND DEVELOPMENT

Выпуск журнала №-24

Часть–1_Апрел –2025

271

nonkeratinized oral mucosa. The prevalence of RAS in the general population varies

from 5% to 66% with a mean of 20%.

1

Kleinman et al.

2

reported a point prevalence

of 1.23% and a lifetime prevalence of 36.5% for RAS in 40,693 USA school children.

In Taiwan, the prevalence of RAS is 10.5% in the general population.

3

Classification of recurrent aphthous stomatitis

Three types of RAS, namely minor, major, and herpetiform types, are

recognized.

1

Minor RAS is the most common type that occurs in 80% of RAS

patients. The oral ulcerative lesions of minor RAS measure between 3 mm and 10 mm

in diameter. They usually arise from the nonkeratinized oral

mucosae

with the buccal

and labial mucosae being affected frequently. The lesion may be preceded by an

erythematous macule with the

prodromal symptoms

of burning or stinging for a few

hours to one or two days. Then, the

oral ulceration

appears and is subsequently

covered by a yellow-white fibrinopurulent pseudomembrane. The oral ulcers heal

without scarring in 7–14 days. Although the minor RAS lesion is small, the pain is

often out of proportion for the size of the

ulceration

.

1

The oral ulcerative lesions of major RAS measure from 1 cm to 3 cm in

diameter. They usually take 2–6 weeks to heal and may lead to scarring. The labial

mucosa,

soft palate

, and tonsillar fauces are most frequently involved. In severe cases,

the repeated scarring processes may result in a limitation of mouth opening.

1

Herpetiform RAS has the greatest number of

oral lesions

and the most

frequent recurrences. Their oral ulcerative lesions vary from 1 mm to 3 mm in

diameter and some of them may coalesce into larger irregular ulcerations. The oral

ulcerations heal between 7 and 10 days. The herpetiform RAS has a female

predilection and a typical onset in adulthood. Herpetiform RAS

oral lesions

may be

confused with those of herpes simplex virus (HSV) type 1 (HSV-1 or HHV-1)

infection. However, the herpetiform RAS lesions are commonly found on

nonkeratinized

oral mucosae

and the HSV-1 lesions are often present on keratinized

oral mucosae such as

gingiva

and

hard palate

.

1


background image

MODERN EDUCATION AND DEVELOPMENT

Выпуск журнала №-24

Часть–1_Апрел –2025

272

Etiology of recurrent aphthous stomatitis

RAS belongs to the group of chronic, inflammatory, ulcerative diseases of the

oral mucosa. Up to date, the etiopathogenesis of this disease remains unclear;

however, it is considered to be multifactorial.

4

The results of previous studies indicate

that genetically mediated disturbances of the innate and acquired immunity play an

important role in the

disease development

. Factors that modify the immunologic

responses in RAS include

genetic predisposition

, viral and bacterial infections,

food

allergies

, vitamin and microelement deficiencies,

systemic diseases

, hormonal

imbalance, mechanical

injuries

, and stress.

4

For the

genetic predisposition

, the positive family history of the RAS was

reported in 24%–46% of RAS cases.

5

,

6

The patients with a positive family history

of RAS suffer more frequent recurrences and more severe course of the disease

compared to those with a negative RAS family history.

7

,

8

,

9

Furthermore, in both

RAS and

Behcet's disease

, the risk of the disease development was higher

in

monozygotic twins

than in

dizygotic twins

,

9

,

10

The

genetic risk factors

that

modify the individual susceptibility to RAS include various

DNA polymorphisms

in

patients, especially those related with the alterations in the metabolism

of

interleukins

(IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12), interferon (IFN)-γ, and

tumor necrosis factor (TNF)-α, can modify the individual susceptibility to RAS.

4

Our

previous studies showed a strong association of HLA-DRw9 with RAS in Chinese

patients and a strong association of anti-epithelial

cell antibodies

with HLA-DR3 or

DR7 phenotype in RAS patients.

11

,

12

In addition, our previous study also demonstrated that the phenotype

frequencies of HLA-DR5, -DRw8 and -DQw1 as well as the haplotype frequencies

of HLA-DR5/DQw1 and HLA-DRw8/DQw1 in patients with the mucocutaneous

type of

Behcet's disease

are significantly higher than those in RAS patients.

Moreover, the relative risks of HLA-DR5/DQw1 and HLA-DRw8/DQw1 haplotypes

are greater than the relative risks of HLA-DR5, HLA-DRw8, and HLA-DQw1

antigens. These results suggest that some specific HLA-DR/DQ haplotypes may be

more important than the individual HLA-DR and HLA-DQ phenotypes in the disease


background image

MODERN EDUCATION AND DEVELOPMENT

Выпуск журнала №-24

Часть–1_Апрел –2025

273

shift from RAS to the mucocutaneous type of BD.

13

In RAS patients, higher

incidences of HLA-A33, HLA-B35 and HLA-B81,

14

HLA-B12,

15

HLA-B51,

16

HLA-

DR7 and HLA-DR5

17

,

18

are observed when compared to healthy control subjects.

Bacterial (

Streptococcus oralis

,

Helicobacter pylori

) and viral (HSV,

varicella-zoster virus,

cytomegalovirus

, and adenoviruses) antigens have been

reported to be potential factors that may modify the immunologic response and

subsequently induce recurrent aphthae in predisposed subjects. However, the results

of these studies are ambiguous and conflicting.

4

In addition, Greenspan

et al.

19

concluded that neither cell-mediated hypersensitivity to streptococcal or viral

antigens nor cross-reactivity between oral mucosal and

streptococcal antigens

is

likely to play a role in the pathogenesis of RAS.

Deficiencies of

hematinics

(iron, vitamin

B12

, and folic acid) and zinc have

been demonstrated in some RAS patients, but it has not been well explained why the

hematinic deficiencies may influence on the course of immune response in RAS.

4

We

tried to explain why

anemia

and hematinic deficiencies might cause the occurrence

of RAS.

20

Deficiencies of iron, vitamin

B12

, or

folic acid

may lead to anemia in RAS

patients. Because RAS patients with anemia have reduced capacity of the blood to

carry oxygen to oral mucosa, finally resulting in atrophy of oral mucosa.

20

Moreover,

iron is essential to the normal functioning of oral epithelial cells,

21

and both vitamin

B12

and

folic

acid

play

important

roles

in

DNA

synthesis

and

cell

division.

22

,

23

Oral epithelial cells have a high turnover rate. Therefore, deficiencies

of iron, vitamin B12, and folic acid may result in oral epithelial atrophy. Atrophic oral

epithelium in hematinic-deficient patients may explain why some patients with

deficiencies

of

hematinics

are

prone

to

have

RAS.

20

Furthermore,

high

blood

homocysteine

level (due to deficiencies of mainly

vitamins B6

and B12 and

folic acid) in some RAS patients may result in an elevated frequency of thrombosis

in the feeding

arterioles

that supply the oral epithelial cells.

24

,

25

,

26

,

27

,

28

This in

turn leads to a breakdown of oral epithelium and finally produces an

oral ulceration

.

Taken

these

together,

anemia,

hematinic

deficiencies,

and

a

high

blood

homocysteine

level can decrease oral epithelial barrier and thus increase the


background image

MODERN EDUCATION AND DEVELOPMENT

Выпуск журнала №-24

Часть–1_Апрел –2025

274

frequency of RAS occurrence.

20

In addition, Volkov et al.

29

found that oral vitamin

B12 supplementation can improve the

symptoms and signs

of RAS regardless of the

initial serum levels of vitamin B12. This finding also confirms the role of

vitamin B12

deficiency

in the development of RAS.

Some previous studies mentioned that exposure to some specific ingredients

(e.g., chocolate,

gluten

,

cow milk

, preservatives, nuts, and food coloring agents) may

induce RAS.

4

However, a previous double-blind study did not confirm the role of

specific food ingredient allergy in the development of RAS.

30

Some

patients

with

systemic

diseases

,

especially

the

Behcet's

disease,

inflammatory bowel diseases

(Crohn's disease, ulcerative colitis),

celiac

disease

, and immunodeficiency virus (HIV) disease, are prone to have

RAS.

1

,

4

Moreover, RAS is one of the criteria for the diagnosis of Behcet's

disease.

1

Patients with

inflammatory bowel diseases

or celiac disease are more likely

to have the complications of

nutrient deficiencies

due to the

malabsorption

of

nutrients. Moreover, these patients tend to have autoimmune reactions that result in

oral aphthous ulcerations.

4

HIV-infected patients are immunocompromised and also

have more chance to develop RAS due to the decrease of CD4 lymphocytes and the

increase of

CD8

lymphocytes.

3

REFERENCES

1. Sánchez-Bernal J, Conejero C, Conejero R. Recurrent Aphthous Stomatitis. Actas

Dermosifiliogr (Engl Ed). 2020 Jul-Aug;111(6):471-480. [PubMed]

2. Chiang CP, Yu-Fong Chang J, Wang YP, Wu YH, Wu YC, Sun A. Recurrent

aphthous stomatitis - Etiology, serum autoantibodies, anemia, hematinic deficiencies,

and management. J Formos Med Assoc. 2019 Sep;118(9):1279-1289. [PubMed]

3. Scully C, Porter S. Oral mucosal disease: recurrent aphthous stomatitis. Br J Oral

Maxillofac Surg. 2008 Apr;46(3):198-206. [PubMed]

4. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent

aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003 Feb;134(2):200-

7. [PubMed]


background image

MODERN EDUCATION AND DEVELOPMENT

Выпуск журнала №-24

Часть–1_Апрел –2025

275

5. Mimura MA, Hirota SK, Sugaya NN, Sanches JA, Migliari DA. Systemic treatment

in severe cases of recurrent aphthous stomatitis: an open trial. Clinics (Sao Paulo).

2009;64(3):193-8. [PMC free article] [PubMed]

6. Savage NW, Seymour GJ, Kruger BJ. Expression of class I and class II major

histocompatibility complex antigens on epithelial cells in recurrent aphthous

stomatitis. J Oral Pathol. 1986 Apr;15(4):191-5. [PubMed]

7. Hasan A, Childerstone A, Pervin K, Shinnick T, Mizushima Y, Van der Zee R,

Vaughan R, Lehner T. Recognition of a unique peptide epitope of the mycobacterial

and human heat shock protein 65-60 antigen by T cells of patients with recurrent oral

ulcers. Clin Exp Immunol. 1995 Mar;99(3):392-7. [PMC free article] [PubMed]

8. Shohat-Zabarski R, Kalderon S, Klein T, Weinberger A. Close association of HLA-

B51 in persons with recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol.

1992 Oct;74(4):455-8. [PubMed]

9. Bazrafshani MR, Hajeer AH, Ollier WE, Thornhill MH. Recurrent aphthous

stomatitis and gene polymorphisms for the inflammatory markers TNF-alpha, TNF-

beta and the vitamin D receptor: no association detected. Oral Dis. 2002

Nov;8(6):303-7. [PubMed]

10. Mizuki N, Ohno S, Sato T, Ishihara M, Miyata S, Nakamura S, Naruse T, Mizuki

H, Tsuji K, Inoko H. Microsatellite polymorphism between the tumor necrosis factor

and HLA-B genes in Behçet's disease. Hum Immunol. 1995 Jun;43(2):129-35.

[PubMed]

11. Huling LB, Baccaglini L, Choquette L, Feinn RS, Lalla RV. Effect of stressful

life events on the onset and duration of recurrent aphthous stomatitis. J Oral Pathol

Med. 2012 Feb;41(2):149-52. [PMC free article] [PubMed]